View Author
scopus: 7103118364

Walter, U.

( U. Walter)


cgk ii cgk i iec-cf 7 cells disease 1441c parkinson carrier iec-cf mutation 125 i efflux protein kinase efflux activation neurology ad-cgk substitution channel membrane cftr cl channels patient phosphorylation lrrk 2 parkinsonism study 8- pcpt-cgmp mutation carriers ad-cgk ii parkinson disease infection haplotype family expression pcpt-cgmp university downloaded adenoviru increase erasmus mc www.neurology.org ad-cgk i jonge activity feature department lohmann forskolin cgmp-dependent analog patch vaandrager response pathology figure plasmid symptom lrrk 2 mutations contrast particle ϯ sd age pig cgk ii parkinson disease k cgmp analogs onset information 8- br-pet-cgmp walter .4321c erasmu part 2 jarchau peptide stably epithelial cells phase br-pet-cgmp ii-infected incidence institute basal




2 Most Recent Publications

Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease (Article)
Haugarvoll, K. Rademakers, R. Guidi, M. Riboldazzi, G. Brown, L. Walter, U. Benecke, R. Berg, D. Gasser, T. Theuns, J. Pals, P. Cras, P. Kachergus, J. Deyn, P.P. de Engelborghs, S. Pickut, B. Uitti, R.J. Foroud, T. Nichols, W.C. Hagenah, J. Klein, C. Samii, A. Zabetian, C.P. Nuytemans, K. Bonifati, V. Broeckhoven, C. van Farrer, M.J. Wszolek, Z.K. Ross, O.A. Gibson, J.M. Tan, E.K. Gaig, C. Tolosa, E. Goldwurm, S.
2008-04-01
cGMP stimulation of cystic fibrosis transmembrane conductance regulator Cl- channels co-expressed with cGMP-dependent protein kinase type II but not type Ibeta (Article)
Vaandrager, A.B. Lohmann, S.M. Jarchau, T. Walter, U. Jonge, H.R. de Poller, W.C. Tilly, B.C. Smolenski, A. Schneider-Rasp, S. Bot, A.G. Edixhoven, M.J. Scholte, B.J.
1997-01-01